JP2021502806A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502806A5 JP2021502806A5 JP2020523795A JP2020523795A JP2021502806A5 JP 2021502806 A5 JP2021502806 A5 JP 2021502806A5 JP 2020523795 A JP2020523795 A JP 2020523795A JP 2020523795 A JP2020523795 A JP 2020523795A JP 2021502806 A5 JP2021502806 A5 JP 2021502806A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- region
- cpg
- methylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 17
- 210000001616 monocyte Anatomy 0.000 claims 10
- 230000011987 methylation Effects 0.000 claims 8
- 238000007069 methylation reaction Methods 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 7
- 239000000523 sample Substances 0.000 claims 6
- 230000010076 replication Effects 0.000 claims 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 238000012544 monitoring process Methods 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 230000003362 replicative effect Effects 0.000 claims 2
- 108091093088 Amplicon Proteins 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 108091029523 CpG island Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 239000012620 biological material Substances 0.000 claims 1
- 238000001369 bisulfite sequencing Methods 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 230000017858 demethylation Effects 0.000 claims 1
- 238000010520 demethylation reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 230000003325 follicular Effects 0.000 claims 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 210000000822 natural killer cell Anatomy 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000005026 transcription initiation Effects 0.000 claims 1
- 238000012546 transfer Methods 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102017125335.1 | 2017-10-27 | ||
| DE102017125335.1A DE102017125335B4 (de) | 2017-10-27 | 2017-10-27 | Amplikon-Region als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere nicht-klassischer Monozyten |
| PCT/EP2018/079406 WO2019081707A1 (en) | 2017-10-27 | 2018-10-26 | AMPLICON REGION AS AN EPIGENETIC MARKER FOR THE IDENTIFICATION OF NON-CLASSIC MONOCYTES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502806A JP2021502806A (ja) | 2021-02-04 |
| JP2021502806A5 true JP2021502806A5 (enExample) | 2021-11-25 |
Family
ID=64024040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523795A Pending JP2021502806A (ja) | 2017-10-27 | 2018-10-26 | 免疫細胞、特に非古典的単球の同定のためのエピジェネティックマーカーとしての単位複製配列領域 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11680294B2 (enExample) |
| EP (1) | EP3669001B1 (enExample) |
| JP (1) | JP2021502806A (enExample) |
| CN (1) | CN111247253A (enExample) |
| AU (1) | AU2018356572A1 (enExample) |
| CA (1) | CA3079477A1 (enExample) |
| DE (1) | DE102017125335B4 (enExample) |
| WO (1) | WO2019081707A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2022191293A1 (enExample) * | 2021-03-12 | 2022-09-15 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2714933A4 (en) | 2011-05-25 | 2014-12-31 | Univ Brown | METHODIZED METHOD FOR IDENTIFYING A CELL OR MIXING CELLS FOR THE PROGNOSIS AND DIAGNOSIS OF ILLNESSES AND FOR CELL HEALING THERAPIES |
| CN105189783B (zh) | 2013-04-19 | 2020-08-07 | 艾皮恩蒂斯有限公司 | 鉴定生物样品中定量细胞组成的方法 |
| US10188679B2 (en) * | 2013-05-22 | 2019-01-29 | Yeda Research And Development Co. Ltd | Human monocyte sub-population for treatment of eye diseases and disorders |
| GB201516975D0 (en) * | 2015-09-25 | 2015-11-11 | Epiontis Gmbh | PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes |
-
2017
- 2017-10-27 DE DE102017125335.1A patent/DE102017125335B4/de active Active
-
2018
- 2018-10-26 WO PCT/EP2018/079406 patent/WO2019081707A1/en not_active Ceased
- 2018-10-26 CA CA3079477A patent/CA3079477A1/en active Pending
- 2018-10-26 CN CN201880068476.5A patent/CN111247253A/zh not_active Withdrawn
- 2018-10-26 US US16/758,992 patent/US11680294B2/en active Active
- 2018-10-26 JP JP2020523795A patent/JP2021502806A/ja active Pending
- 2018-10-26 AU AU2018356572A patent/AU2018356572A1/en not_active Abandoned
- 2018-10-26 EP EP18793655.4A patent/EP3669001B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2904658C (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| Rakyan et al. | Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains | |
| EP1826279B1 (en) | Detection and quality control of regulatory T cells through DNA-methylation analysis of the FoxP3 gene | |
| NZ786186A (en) | Determination of base modifications of nucleic acids | |
| JP2018529345A5 (enExample) | ||
| JP2018529346A5 (enExample) | ||
| US20210024999A1 (en) | Method of identifying risk for autism | |
| Baria et al. | Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition | |
| WO2015042980A1 (zh) | 确定染色体预定区域中snp信息的方法、系统和计算机可读介质 | |
| US9096900B2 (en) | Epigenetic marker for the identification of natural killer cells | |
| JP2018534910A5 (enExample) | ||
| US20200270683A1 (en) | Methods for obtaining embryonic stem cell dna methylation signatures | |
| EP4540410A2 (en) | Methods for determination and monitoring of transplant rejection by measuring rna | |
| JP2021502806A5 (enExample) | ||
| JP6113159B2 (ja) | ナチュラルキラー細胞を同定するエピジェネティックマーカー | |
| Sasaki et al. | Genome-wide epigenetic signatures of childhood adversity in early life: opportunities and challenges | |
| WO2024137407A1 (en) | Methods and targets of dna methylation entropy | |
| EP3055425B1 (en) | Predicting increased risk for cancer | |
| JP2021502809A5 (enExample) | ||
| Chen et al. | Single-cell multi-omics reveals elevated plasticity and stem-cell-like blasts relevant to the poor prognosis of KMT2A-rearranged leukemia | |
| Kular et al. | DNA Methylation in Multiple Sclerosis | |
| WO2022191293A1 (ja) | 全単球及びｃｄ１６陽性単球の割合の測定方法 | |
| Fernández et al. | H3K4me1 marks DNA regions hypomethylated during aging in | |
| CN119144710A (zh) | 用于急性移植物抗宿主病风险预测和造血细胞移植前供者筛选的基因组合及其应用 | |
| NZ772327B2 (en) | Determination of base modifications of nucleic acids |